Skip to content
Unrated Drug recall · FDA · Published October 9, 2026

AvKARE Recalls Fludrocortisone Acetate Tablets Due to Impurities

AvKARE is recalling 8,866 cartons of Fludrocortisone Acetate Tablets due to failed impurity specifications. Check your lot number and expiration date.

🇺🇸 FDA recall #D-0157-2027DrugAvKARE ›
✎ GovInfoNow plain-language explainer

AvKARE has recalled one lot of Fludrocortisone Acetate Tablets, USP 0.1mg because the product failed impurity and degradation specifications. The affected items are 50-tablet unit dose AVPAKs distributed nationwide. The record does not specify any known injuries or a current remedy for consumers. Read more at govinfonow.com/recall/2249418-avkare-recalls-fludrocortisone-acetate-tablets-usp-0-1mg-rx-only.

Source Summary by GovInfoNow · govinfonow.com/recall/2249418-avkare-recalls-fludrocortisone-acetate-tablets-usp-0-1mg-rx-only · Published November 17, 2026 · Updated November 17, 2026 · FDA enforcement record: FDA #D-0157-2027

Cite this page

“AvKARE Recalls Fludrocortisone Acetate Tablets Due to Impurities.” GovInfoNow, updated November 17, 2026. https://govinfonow.com/recall/2249418-avkare-recalls-fludrocortisone-acetate-tablets-usp-0-1mg-rx-only. Based on FDA recall #D-0157-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0157-2027%22&limit=1).

The FDA announced on Oct. 9, 2026, that AvKARE is voluntarily recalling Fludrocortisone Acetate Tablets due to failed impurities and degradation specifications. The recall affects 8,866 cartons distributed nationwide.

How to tell if you have it

  • Brand: AvKARE
  • Product: Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 50 Tablets (5 x 10) Unit Dose AVPAK
  • NDC: 50268-330-15
  • Lot #: 48353
  • Expiration Date: 10/31/2026

The hazard

The recall is due to failed impurities and degradation specifications. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show AvKARE has had 14 other recalls since March 28, 2024. Recent similar recalls include the AvKARE Amantadine Capsules Recall (Feb. 13, 2026), the AvKARE Rosuvastatin Tablets 10mg Recall (Dec. 31, 2025), and the AvKARE Hormone Tablets Recall (Sept. 2, 2025). Other recent recalls of similar products include the Sun Pharmaceutical Fluocinolone Acetonide Solution Recall (Dec. 30, 2025), the Ajanta Pharma Fluphenazine Tablets Recall (Aug. 25, 2026), and the Ritedose Formoterol Fumarate Inhalation Solution Recall (Oct. 15, 2026).

How to tell if you have this one

Look for Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, in a 50 Tablet (5 x 10) Unit Dose AVPAK. The package should be manufactured for AvKARE in Pulaski, TN 38748, with NDC 50268-330-15, Lot # 48353, and an expiration date of 10/31/2026.

  • Brand
    AvKARE
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 33 days after the firm started it.

1. Firm started the recall: Oct 9, 202612. FDA classified it Class II: Oct 30, 202623. Published in FDA’s Enforcement Report: Nov 11, 202634. Added to GovInfoNow: Nov 17, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0157-2027 (October 9, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0157-2027 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on November 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA